Viewing StudyNCT00437073



Ignite Creation Date: 2024-05-05 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00437073
Status: TERMINATED
Last Update Posted: 2015-10-15
First Post: 2007-02-15

Brief Title: Brain Metastases In ErbB2-Positive Breast Cancer
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
XELODA View
brain metastases View
ErbB2 View
lapatinib View
Breast Cancer View
HYCAMTIN View
topotecan View
capecitabine View
metastatic breast cancer View
TYKERB View